Podcasts & RSS Feeds
Most Active Stories
- Don't like the water shut-offs in Detroit? Now you can pay someone's overdue water bill
- Proposal 1 asks Michigan voters to weigh in on a complex tax issue
- Approaching construction on the highway? Experts say the "zipper merge" can help
- These three female candidates could be some of the most interesting leaders in Michigan
- This ballot proposal is critical to Michigan's economy, but most people won't bother to vote on it
Mon October 3, 2011
Supreme Court won’t hear drugmaker immunity challenge
Michigan will be not able to recover millions of dollars by spent by the Medicaid program on the drug Vioxx. The Michigan Supreme Court has refused to hear the appeal of a lower court ruling that said the lawsuit is barred by the state’s drug company immunity law.
Michigan has a one-of-a-kind law that shields drug manufacturers from product liability lawsuits as long as the medication was approved by the U.S. Food and Drug Administration.
The law was enacted in the 1990s to help make Michigan more attractive to drug makers. Vioxx was a controversial medication used to treat asthma, but it was pulled from the market in 2004 after it was linked to an increased risk of heart attacks and complaints that Merck tried to cover up the dangers posed by the drug.
Michigan’s lawsuit claims Merck failed to warn the state of the potential dangers when the drug was approved for use by Medicaid patients. The Supreme Court’s rejection lets stand a lower court decision tossing the case.